Workflow of the clinical note–based question-answering system powered by the rag architecture. Credit: NEJM AI (2024). DOI: 10.1056/AIoa2400181 Generative Artificial Intelligence (Gen AI) can rapidly and accurately screen patients for clinical trial eligibility, according to a new study from Mass General Brigham researchers. Such technology could make it faster and cheaper to evaluate new treatments and, ultimately, help bring successful ones to patients. Investigators assessed the accuracy and cost of a Gen AI process they named RAG-Enabled Clinical Trial Infrastructure for Inclusion Exclusion Review (RECTIFIER), that identifies patients who meet Read More